ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Otolaryngology

Top Otolaryngology Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RUSSELL CECOLA M.D.

Otolaryngology

2,602

$109K

817
659 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $52

VIRGINIA BRINGAZE MD

Otolaryngology

2,076

$119K

465
401 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $52

RENICK WEBB M.D.

Otolaryngology

1,954

$90K

476
334 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $52

RICHARD HEBERT M.D.

Otolaryngology

1,859

$129K

431
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$69
Average prescription price

Avg: $52

BRIAN PETIT MD

Otolaryngology

1,775

$94.8K

386
354 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $52

BRADLEY CHASTANT MD

Otolaryngology

1,745

$126K

422
331 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 23%

$72
Average prescription price

Avg: $52

PAUL SPRING

Otolaryngology

1,514

$34.2K

531
425 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 23%

$23
Average prescription price

Avg: $52

PAUL GUILLORY M.D.

Otolaryngology

1,481

$83.7K

411
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $52

ROY FLENIKEN M.D.

Otolaryngology

1,279

$81.8K

78
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $52

THOMAS IRWIN MD

Otolaryngology

1,253

$35.4K

336
246 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 23%

$28
Average prescription price

Avg: $52

CHARLES MITCHELL M.D.

Otolaryngology

1,199

$90K

385
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $52

JACQUES PELTIER M.D.

Otolaryngology

1,151

$78.8K

333
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $52

LAWRENCE DANNA MD

Otolaryngology

1,132

$69.5K

332
292 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $52

MICHAEL GRIFFIN PA

Otolaryngology

1,124

$75K

281
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $52

MONTY RIZZO MD

Otolaryngology

1,109

$49.3K

216
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $52

MARK PETITJEAN M.D.

Otolaryngology

1,085

$53.5K

263
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $52

GEORGE WALKER MD

Otolaryngology

1,061

$26K

96
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

52%
patients receiving schedule three controlled substances

Avg: 7%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 23%

$24
Average prescription price

Avg: $52

JUSTIN TENNEY M.D.

Otolaryngology

1,058

$41.6K

304
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $52

JEFFREY LACOUR M.D.

Otolaryngology

1,016

$55.3K

293
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $52

STEPHEN GOODWIN MD

Otolaryngology

1,007

$33.1K

364
276 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $52

EDWIN ROSS MD

Otolaryngology

1,006

$24.9K

355
284 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 23%

$25
Average prescription price

Avg: $52

SALLY SARTOR M.D.

Otolaryngology

1,003

$64.6K

265
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $52

CHARLES NEAL M.D.

Otolaryngology

994

$46.2K

264
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $52

CHARLES LEBLANC M.D.

Otolaryngology

969

$61.9K

351
304 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $52

MICHAEL ROBICHAUX M.D.

Otolaryngology

949

$22.9K

287
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 23%

$24
Average prescription price

Avg: $52

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank